JP2006525328A5 - - Google Patents

Download PDF

Info

Publication number
JP2006525328A5
JP2006525328A5 JP2006509943A JP2006509943A JP2006525328A5 JP 2006525328 A5 JP2006525328 A5 JP 2006525328A5 JP 2006509943 A JP2006509943 A JP 2006509943A JP 2006509943 A JP2006509943 A JP 2006509943A JP 2006525328 A5 JP2006525328 A5 JP 2006525328A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
combination
cardiovascular disease
prevention
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006509943A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006525328A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/011257 external-priority patent/WO2004098713A2/en
Publication of JP2006525328A publication Critical patent/JP2006525328A/ja
Publication of JP2006525328A5 publication Critical patent/JP2006525328A5/ja
Pending legal-status Critical Current

Links

JP2006509943A 2003-05-05 2004-04-26 心疾患の治療方法 Pending JP2006525328A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46790303P 2003-05-05 2003-05-05
PCT/US2004/011257 WO2004098713A2 (en) 2003-05-05 2004-04-26 Treating cardiovascular diseases with a compound of formula (i) (cs 747 - prasugrel; rn 150322-43-4)

Publications (2)

Publication Number Publication Date
JP2006525328A JP2006525328A (ja) 2006-11-09
JP2006525328A5 true JP2006525328A5 (cg-RX-API-DMAC7.html) 2007-01-18

Family

ID=33435139

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006509943A Pending JP2006525328A (ja) 2003-05-05 2004-04-26 心疾患の治療方法

Country Status (4)

Country Link
US (1) US20060217351A1 (cg-RX-API-DMAC7.html)
EP (1) EP1660183A2 (cg-RX-API-DMAC7.html)
JP (1) JP2006525328A (cg-RX-API-DMAC7.html)
WO (1) WO2004098713A2 (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8137397B2 (en) * 2004-02-26 2012-03-20 Boston Scientific Scimed, Inc. Medical devices
KR20080016647A (ko) * 2005-06-17 2008-02-21 일라이 릴리 앤드 캄파니 프라수그렐에 대한 투여 계획
JP2009504737A (ja) * 2005-08-19 2009-02-05 イーライ リリー アンド カンパニー 脈管疾患の治療又は予防のためのpar−1/par−4阻害剤の使用
EP2436381A1 (en) * 2006-06-27 2012-04-04 Sandoz AG Crystallization of hydrohalides of pharmaceutical compounds
CA2672134C (en) * 2006-12-07 2015-02-10 Daiichi Sankyo Company, Limited Solid medicinal preparation containing mannitol or lactose
KR101665705B1 (ko) * 2006-12-07 2016-10-12 다이이찌 산쿄 가부시키가이샤 안정성이 개선된 필름 코팅 제제
TWI482641B (zh) 2006-12-07 2015-05-01 Daiichi Sankyo Co Ltd 含有低取代度羥丙基纖維素之醫藥組成物
WO2008072533A1 (ja) 2006-12-07 2008-06-19 Daiichi Sankyo Company, Limited 固形製剤の製造方法
JPWO2008072532A1 (ja) * 2006-12-07 2010-03-25 第一三共株式会社 貯蔵安定性が改善された医薬組成物
CN102424686A (zh) * 2007-03-02 2012-04-25 第一三共株式会社 用于制备高纯度普拉格雷盐酸盐的方法
CN101686681B (zh) 2007-04-27 2015-04-01 锡德克斯药物公司 包含氯吡格雷和磺基烷基醚环糊精的制剂和其使用方法
US20100261908A1 (en) * 2007-11-09 2010-10-14 Dr. Reddy's Laboratories Ltd. Processes for the preparation of prasugrel , and its salts and polymorphs
HU230262B1 (hu) * 2007-11-27 2015-11-30 Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság Eljárás gyógyszeripari intermedierek előállítására
US20090281136A1 (en) * 2008-05-08 2009-11-12 Sandeep Mhetre Prasugrel pharmaceutical formulations
WO2010094471A1 (en) * 2009-02-17 2010-08-26 Krka, D. D., Novo Mesto Pharmaceutical compositions comprising prasugrel base or its pharmaceutically acceptable acid addition salts and processes for their preparation
PL3100728T3 (pl) 2009-05-13 2020-05-18 Cydex Pharmaceuticals, Inc. Kompozycje farmaceutyczne zawierające prasugrel i pochodne cyklodekstryny oraz sposoby ich wytwarzania i zastosowania
JP5795585B2 (ja) * 2009-08-28 2015-10-14 ハーキュリーズ・インコーポレーテッドHercules Incorporated 固体粉末化合物からのフィルムコーティング組成物
EP2275087B8 (en) * 2010-02-22 2012-11-21 Jrs Pharma GmbH+Co.kG Prasugrel controlled release formulations
CN102869668A (zh) 2010-03-09 2013-01-09 斯索恩有限公司 制备普拉格雷的方法
TR201006802A1 (tr) * 2010-08-17 2012-03-21 Sanovel İlaç San. Ve Ti̇c. A.Ş. Prasugrelin oral yolla dağılan formülasyonları.
EP2409685A3 (en) * 2010-07-19 2012-02-01 Sanovel Ilac Sanayi ve Ticaret A.S. Orally-disintegrating formulations of prasugrel
CN102775422B (zh) * 2012-03-13 2014-12-31 山东新华制药股份有限公司 普拉格雷中间体的一种晶型
CN102993210A (zh) * 2012-12-19 2013-03-27 苏春华 一种吡啶并噻吩的新化合物
CN104418718B (zh) * 2013-08-28 2018-04-13 山东新时代药业有限公司 一种环丙基‑2‑溴‑2‑(2‑氟苯基)乙酮的制备方法
CN107304216A (zh) * 2016-04-20 2017-10-31 陕西合成药业股份有限公司 噻吩吡啶类衍生物及其制备方法和用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3191597A (en) * 1996-06-26 1998-01-14 Sankyo Company Limited Novel medicinal compositions of hydropyridines
JP3274088B2 (ja) * 1996-08-28 2002-04-15 三共株式会社 環状アミン誘導体
JP3907029B2 (ja) * 1998-02-27 2007-04-18 三共株式会社 環状アミン誘導体を含有する医薬
US6509348B1 (en) * 1998-11-03 2003-01-21 Bristol-Myers Squibb Company Combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination
JP2001131067A (ja) * 1999-08-26 2001-05-15 Sankyo Co Ltd 血小板凝集抑制剤又は動脈硬化進展抑制剤
WO2001044239A2 (en) * 1999-12-15 2001-06-21 Bristol-Myers Squibb Co. Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
KR20080021152A (ko) * 2000-07-06 2008-03-06 다이이찌 산쿄 가부시키가이샤 히드로피리딘 유도체 산부가염
JP4001199B2 (ja) * 2000-07-06 2007-10-31 第一三共株式会社 ヒドロピリジン誘導体酸付加塩
CZ297570B6 (cs) * 2000-12-25 2007-02-07 Sankyo Company, Limited Farmaceutický prípravek obsahující 2-acetoxypyridinový derivát a aspirin, které spolu pusobí v synergickém úcinku, kit jej obsahující a pouzití
JP2002348235A (ja) * 2001-03-23 2002-12-04 Clinical Supply:Kk 再狭窄予防剤

Similar Documents

Publication Publication Date Title
US11103467B2 (en) Method for treating depression
JP2015057436A5 (cg-RX-API-DMAC7.html)
RU2004126950A (ru) Использование выделяющих co соединений при изготовлении лекарственного средства для лечения воспалительных заболеваний
KR101675501B1 (ko) 클로피도그렐 및 아스피린의 복합제제
HRP20140645T1 (hr) Uporabe dpp-iv inhibitora
JP2007119479A5 (cg-RX-API-DMAC7.html)
JP5911969B2 (ja) 心臓血管障害の治療方法
FI3562487T3 (fi) Metalloentsyymi-inhibiittoriyhdisteitä
JP2014077003A5 (cg-RX-API-DMAC7.html)
RU2005118750A (ru) Органические соединения
JP6657420B2 (ja) クロピドグレル及びアスピリンを含む複合製剤
JP2006525328A (ja) 心疾患の治療方法
JP2014532726A5 (cg-RX-API-DMAC7.html)
CN102149377A (zh) 决奈达隆在制备用于预防中风或短暂性缺血发作的药物中的用途
CN106618821B (zh) 一种防止血管再狭窄的血管支架及其制备方法
Goldschmidt et al. Compound cardiac toxicity of oral erythromycin and verapamil
JP2020510616A5 (cg-RX-API-DMAC7.html)
JP2016516031A5 (cg-RX-API-DMAC7.html)
CN101496792A (zh) 普萘洛尔或其盐的迟释制剂及其制备方法
CN103025707B (zh) 泛醇基二十二碳六烯酸酯及其治疗和预防心血管疾病的用途
Moothart et al. The heritable syndrome of prolonged QT interval, syncope, and sudden death: electron microscopic observations
JP2008524228A5 (cg-RX-API-DMAC7.html)
Rosenkranz et al. Hotline Update of Clinical Trials and Registries presented at the German Cardiac Society Meeting 2007: 2L-Registry, Kardio-Pro, EVER, AFFECT, VTACH, ARTS II, OPTAMI, PEPCAD I, PEPCAD II, GERSHWIN, SPICE, FIX-CHF and CREDI
RU2019109050A (ru) Композиции тезофензина
Fang et al. Recurrent cerebral embolism and impending detachment of a previous nonmobile left atrial thrombus following initiation of anticoagulant therapy in a patient with nonvalvular atrial fibrillation